Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Expenses (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Operating Expenses data on record, last reported at $97.0 million in Q4 2025.

  • For Q4 2025, Operating Expenses rose 35.88% year-over-year to $97.0 million; the TTM value through Dec 2025 reached $326.2 million, up 56.29%, while the annual FY2025 figure was $326.2 million, 56.29% up from the prior year.
  • Operating Expenses reached $97.0 million in Q4 2025 per PRAX's latest filing, up from $78.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $97.0 million in Q4 2025 and bottomed at $26.0 million in Q3 2023.
  • Average Operating Expenses over 4 years is $54.9 million, with a median of $50.7 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: tumbled 43.68% in 2023, then surged 152.18% in 2024.
  • A 4-year view of Operating Expenses shows it stood at $41.5 million in 2022, then plummeted by 31.68% to $28.3 million in 2023, then soared by 152.18% to $71.4 million in 2024, then surged by 35.88% to $97.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $97.0 million in Q4 2025, $78.4 million in Q3 2025, and $76.1 million in Q2 2025.